“A lot of my friends are in their late 50s, and they’re already talking about, ‘OK, maybe in the next 5 years, 10 years at most, I’m going to retire.'” — Bobby Mukkamala, MD, president of the American Medical Association, discussing the ongoing physician shortage and other priorities for the organization.
“History shows that politicizing delivery of healthcare leads to horrible consequences, from the Nazis to Stalin — even to Mao Zedong.” — Arthur Caplan, PhD, of NYU Langone Health, on a disputed story that claimed a Veterans Affairs policy could allow medical staff to reject patients based on political party or marital status.
“It’s like you’ve got to have a car that’s better than a neighbor’s car.” — Bryan Carmody, MD, of Eastern Virginia Medical School in Norfolk, on “score creep” that led to a higher bar for passing the U.S. Medical Licensing Examination Step 2 clinical knowledge test.
“Consider the mortality impacts of this legislation, which would save money mostly for the purpose of tax cuts for the wealthy.” — Adam Gaffney, MD, of Cambridge Health Alliance in Boston, on estimated preventable deaths from Medicaid cuts.
“The effects that we estimated in this study may be small on an individual level, but are quite meaningful when you consider the entire population that is exposed.” — Anne Nigra, ScM, PhD, of Columbia University Mailman School of Public Health in New York City, discussing links between adverse birth outcomes and prenatal exposure to arsenic in the public water supply.
“This paradoxical reaction highlights the need for increased clinical awareness when evaluating new-onset psoriasiform lesions in patients receiving dupilumab.” — Shoshana Marmon, MD, PhD, of New York Medical College in Valhalla, on increased psoriasis risk associated with using dupilumab (Dupixent) for atopic dermatitis.
“It’s not just taking something away, but really doing a careful assessment of how that medication works within that particular individual and how can we support them.” — Emily Brunner, MD, of the Hazelden Betty Ford Foundation in Minneapolis, discussing a new guideline on benzodiazepine tapering.
